Optimal control of tumour-immune model with time-delay and immuno-chemotherapy

From MaRDI portal
Publication:2010733

DOI10.1016/j.amc.2019.02.002zbMath1428.92052OpenAlexW2916951179WikidataQ128386346 ScholiaQ128386346MaRDI QIDQ2010733

Yanyan Li

Publication date: 27 November 2019

Published in: Applied Mathematics and Computation (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.amc.2019.02.002




Related Items (17)

Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approachParameter estimation and sensitivity analysis for a model of tumor-immune interaction in the presence of immunotherapy and chemotherapyOn the optimal control of coronavirus (2019-nCov) mathematical model; a numerical approachStudy of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancerStability and bifurcation analysis of a tumor-immune system with two delays and diffusionOptimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approachAN ADAPTIVE PHARMACOKINETIC OPTIMAL CONTROL APPROACH IN CHEMOTHERAPY FOR HETEROGENEOUS TUMOROptimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapyOptimal control and cost-effectiveness analysis for a COVID-19 model with individual protection awarenessAn optimal control problem of immuno-chemotherapy in presence of gene therapyDynamics of fractional-order delay differential model for tumor-immune systemDynamic behaviors and optimal control of a new delayed epidemic modelBifurcation analysis and optimal control of a delayed single-species fishery economic modelOptimal control problem for a general reaction-diffusion tumor-immune system with chemotherapyA fractional-order model for zika virus infection with multiple delaysA multi-drug pharmacokinectic optimal control approach in cancer chemotherapyA NEW MATHEMATICAL MODELING AND SUB-OPTIMAL CHEMOTHERAPY OF CANCER


Uses Software


Cites Work


This page was built for publication: Optimal control of tumour-immune model with time-delay and immuno-chemotherapy